SAFE APPLICATION OF DESMOPRESSINUM Russian patent published in 2015 - IPC A61K38/22 A61K9/12 A61P13/00 

FIELD: medicine, pharmaceutics.

SUBSTANCE: group of inventions relates to the field of medicine and deals with a pharmaceutical composition for inducing an antidiuretic effect in a patient with the reduction of the risk that hyponatremia can develop in the patient, which contains an intranasal dose of desmopressinum for spraying in the form of a conic torch ejected through some time interval from the nozzle, which measures a dose for a spraying device, with the device itself being disclosed. Described is a family of intranasal aerosol dosing devices for the introduction of similar low doses of desmopressinum in such a way as to reach safe depression of urine secretion by kidneys in humans. The dosing devices in accordance with the claimed invention can be applied in the treatment of nocturnal polyuria, primary nocturnal enuresis, incontinence, micturition frequency, diabetes insipidus or any disease or syndrome, when therapy with desmopressinum is applicable.

EFFECT: group of inventions ensures safe temporal suppression of urine production, which can result in favourable effects on the health or increased comfort in micturition regulation.

25 cl, 10 dwg, 5 tbl, 4 ex